Format

Send to

Choose Destination
Biomed Pharmacother. 2019 Feb;110:431-439. doi: 10.1016/j.biopha.2018.11.135. Epub 2018 Dec 5.

SUR2B/Kir6.1 channel openers correct endothelial dysfunction in chronic heart failure via the miR-1-3p/ET-1 pathway.

Author information

1
Department of Environment Medicine, Tianjin Institute of Environmental and Operational Medicine, Tianjin, 300050, China.
2
State Key Lab of NBC Protection for Civilian, Research Institute of Chemical Defense, No. 1 Huaiyin Road, Beijing, 102205, China.
3
Department of Environment Medicine, Tianjin Institute of Environmental and Operational Medicine, Tianjin, 300050, China; The 307 Military Hospital, Academy of Military Medical Sciences, Beijing, 100850, China.
4
Department of Environment Medicine, Tianjin Institute of Environmental and Operational Medicine, Tianjin, 300050, China. Electronic address: 13389990368@163.com.
5
The 307 Military Hospital, Academy of Military Medical Sciences, Beijing, 100850, China; Cardiovascular Drug Research Center, Thadweik Academy of Medicine, Beijing, 100039, China. Electronic address: wh9588@sina.com.

Abstract

The SUR2B/Kir6.1 channel openers iptakalim and natakalim reverse cardiac remodeling and ameliorate endothelial dysfunction by re-establishing the balance between the nitric oxide and endothelin systems. In this study, we investigated the microRNAs (miRs) involved in the molecular mechanisms of SUR2B/Kir6.1 channel opening in chronic heart failure. Both iptakalim and natakalim significantly upregulated the expression of miR-1-3p, suggesting that this miR is closely associated with the therapeutic effects against chronic heart failure. Bioinformatic analysis showed that many of the 183 target genes of miR-1-3p are involved in cardiovascular diseases, suggesting that miR-1-3p plays a vital role in such diseases and vascular remodeling. Target gene prediction showed that miR-1-3p combines with the 3' untranslated region (UTR) of endothelin-1 (ET-1) mRNA. Iptakalim and natakalim upregulated miR-1-3p expression and downregulated ET-1 mRNA expression in vitro. The dual luciferase assay confirmed that there is a complementary binding sequence between miR-1-3p and the 3' UTR 158-165 sequence of ET-1 mRNA. To verify the effect of miR-1-3p on ET-1, lentiviral vectors overexpressing or inhibiting miR-1-3p were constructed for the transduction of rat primary cardiac microvascular endothelial cells. The results showed that natakalim enhanced the miR-1-3p level. miR-1-3p overexpression downregulated the expression of ET-1, whereas miR-1-3p inhibition had the opposite effect. Therefore, we verified that SUR2B/Kir6.1 channel openers could correct endothelial imbalance and ameliorate chronic heart failure through the miR-1-3p/ET-1 pathway in endothelial cells. Our study provides comprehensive insights into the molecular mechanisms behind the SUR2B/Kir6.1 channel's activity against chronic heart failure.

KEYWORDS:

Chronic heart failure; Endothelial function; Iptakalim; Natakalim; SUR2B/Kir6.1 channel; miRNA

PMID:
30530045
DOI:
10.1016/j.biopha.2018.11.135
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center